Abstract
Licorice as a kind of traditional Chinese medicine is widely used for more than one thousand years. Modern studies show that Licorice has antibacterial, antiviral, antioxidant, and other pharmacological effects. In recent years, the anti-tumor effect of Licorice has evoked the great interest due to its bioactive ingredients. The most active ingredients in Licorice mainly include triterpenes, flavonoids, polysaccharides, and so on. In this review, a comprehensive overview on the active ingredients of Glycyrrhiza and its antitumor mechanism was addressed.
Keywords: Glycyrrhizic acid, glycyrrhetinic acid, glycyrrhizic flavones, glycyrrhizic amylose, anticancer
Current Bioactive Compounds
Title: Research Advances on Anticancer Effect of Licorice
Volume: 5 Issue: 3
Author(s): Tianshui Niu, Jianshe Yang, Long Zhang, Xiao Cheng, Kai Li and Gang Zhou
Affiliation:
Keywords: Glycyrrhizic acid, glycyrrhetinic acid, glycyrrhizic flavones, glycyrrhizic amylose, anticancer
Abstract: Licorice as a kind of traditional Chinese medicine is widely used for more than one thousand years. Modern studies show that Licorice has antibacterial, antiviral, antioxidant, and other pharmacological effects. In recent years, the anti-tumor effect of Licorice has evoked the great interest due to its bioactive ingredients. The most active ingredients in Licorice mainly include triterpenes, flavonoids, polysaccharides, and so on. In this review, a comprehensive overview on the active ingredients of Glycyrrhiza and its antitumor mechanism was addressed.
Export Options
About this article
Cite this article as:
Niu Tianshui, Yang Jianshe, Zhang Long, Cheng Xiao, Li Kai and Zhou Gang, Research Advances on Anticancer Effect of Licorice, Current Bioactive Compounds 2009; 5 (3) . https://dx.doi.org/10.2174/157340709789054803
DOI https://dx.doi.org/10.2174/157340709789054803 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications
Current Medicinal Chemistry Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry It Takes Two to Tango: The Structure and Function of LIM, RING, PHD and MYND Domains
Current Pharmaceutical Design Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
Current Medicinal Chemistry - Anti-Cancer Agents New Biomarkers for Colon Cancer Diagnosis: A Review of Recent Patents
Recent Patents on Biomarkers Vulvar Leiomyomatosis: A Diagnostic Challenge Case Report
Current Women`s Health Reviews Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Interaction of Small Cationic Peptides with Intact Basement Membranes. A Study Using Intrinsic Optical Signals of Chick Retinas
Current Medicinal Chemistry Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Current Medicinal Chemistry Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines
Protein & Peptide Letters Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Clinical Aspects of Tumor Necrosis Factor-α Signaling in Hepatocellular Carcinoma
Current Pharmaceutical Design Mesenchymal Stem Cell Therapy for Equine Tendinitis
Recent Patents on Regenerative Medicine Current Trends in the Use of Cationic Polymer Assemblies for siRNA and Plasmid DNA Delivery
Pharmaceutical Nanotechnology Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Current Pharmaceutical Design